The concept of gene therapy has been brought up as an alternative to chemotherapy to treat these aggressive cancers (66, 67) in this case RNAi could be used to target mutated proteins which are a product of missense mutations, leading to high constitutive expression of mutated proteins such as TP53 (68). This evidence concerns the gene TP53 and cancer.